Hologic (NSDQ:HOLX) beat its own earnings forecast for its fiscal 3rd quarter and met its sales guidance, but still lowered its revenues and earnings outlook for the rest of the year.
MassDevice Earnings Roundup
Volcano gains on Street-beating Q2 earnings
Wright Medical’s Q2 losses grow on merger, sale costs
Second-quarter losses grew for Wright Medical (NSDQ:WMGI) as the medical device company continued to absorb its acquisition of BioMimetic Therapeutics and to deal with the sale of its hip & knee implant business.
Hanger shares plunge on Q2 earnings
Hanger Inc. (NYSE:HGR) missed the mark in the 2nd quarter, posting numbers that came in well below the Street’s expectations, missing analysts average per-share estimates by 7¢.
Natus continues to slide on underwhelming Q2 results
San Carlos, Calif.-based Natus Medical (NSDQ:BABY) lost a few more points after releasing its official Q2 earnings release, which was pretty much in line with the company’s preliminary report.
Endologix shares gain 5 points in days following Q2 report
Special charges devour Merit Medical’s bottom line in Q2
Merit Medical Systems (NSDQ:MMSI) saw its bottom line drop dramatically during its 2nd quarter, thanks in part to some high-value temporary expenses, but the device maker’s otherwise promising financials got some attention from Wall Street last week.
Cynosure falls back to earth after reporting Q2 results
ResMed settles down after earnings release high
Sales are flat, profits plunge in the 2nd quarter for Symmetry Medical
Symmetry Medical (NYSE:SMA) saw its 2nd-quarter profits plunge more than 28% on flat sales and lowered its outlook for the balance of the year.
Dentsply’s Q2 earnings rise despite flat sales
Dentsply International (NSDQ:XRAY) managed to boost its 2nd-quarter profits despite flat sales, saying headwinds in Europe will push down its earnings for the rest of the year.